N/A N=1,100 Online Survey in Studying Smoking Attitudes and Behaviors Among Current Smokers
Smoker
Primary: Quit Intentions — 1.90; 1.72; 1.89; 1.79 units on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=309 A Study of ALKS 3831 in Adults With Schizophrenia
Schizophrenia
Primary: Absolute Change in Total Positive and Negative Syndrome Scale (PANSS) Score — -2.9; -1.5; -2.7; -2.5 units on a scale — p=0.3
N/A N=176 Patient Controlled Analgesia Pump Cues on Patient Satisfaction
Postoperative Pain
Primary: Patient Satisfaction Questionnaire — 8; 7.5 units on a scale
Phase 3 N=376 Efficacy and Safety of Oral Ibrexafungerp (SCY-078) vs. Placebo in Subjects With Acute Vulvovaginal Candidiasis (VANISH 303)
Candida Vulvovaginitis
Primary: Clinical Cure (Complete Resolution of Signs and Symptoms) — 95; 28; 93; 70 Participants
Phase 4 N=27 Belatacept 3 Month Post Transplant Conversion Study
Transplant; Failure, Kidney · EBV
Primary: Change in eGFR (MDRD) at 2 Years Post-transplant Compared to Baseline at Month 3 (Conversion) — -5.44; 8.08; -0.38 mL/min/1.73m2
Phase 3 N=552 A Safety and Efficacy Comparison of BLI4700 Bowel Prep Versus an FDA-approved Comparator in Adults Prior to Colonoscopy
Colonoscopy
Primary: Number and Percentage of Subjects With Successful Bowel Cleansing — 257; 241 Participants — p=<0.001
Phase 3 N=680 Investigational Therapeutics for the Treatment of People With Ebola Virus Disease
Ebola Virus
Primary: Mortality — 93; 61; 52; 84 deaths
N/A N=11,976 Aspirin Supplementation for Pregnancy Indicated Risk Reduction In Nulliparas (ASPIRIN)
Premature Birth
Primary: Incidence of Preterm Birth — 668; 754 Participants — p=0.012
N/A N=3,013 A Post Marketing Surveillance (PMS) Study to Monitor the Safety of GlaxoSmithKline (GSK) Biologicals' Human Papillomavirus (HPV) Vaccine in Female Chinese Subjects
Cervical Intraepithelial Neoplasia
Primary: Number of Participants With Any (Following Each Dose and Across Doses), Grade 3 (Across Doses) and Vaccine Related (Across Doses) Medically Attended Adverse Events…
Phase 4 N=10 Drug-Drug Interaction Between Rifampin and Fluvastatin
Drug-drug Interaction
Primary: AUC — 242; 642; 124; 371 ng/mL·h
Phase 3 N=389 A Safety and Efficacy Comparison of BLI4700 Bowel Preparation Versus an FDA-approved Comparator in Adult Subjects Prior to Colonoscopy
Colonoscopy
Primary: Number and Percentage of Subjects With Successful Bowel Cleansing — 175; 174 Participants — p=<0.001
N/A N=229 Hostile Bias Modification Training Online Study II
Aggression · Anger · Emotion Regulation
Primary: Hostile Attribution Bias — 9.4; 10.8 score on a scale — p=<.001
N/A N=696 Developing and Testing Implementation Strategies for Evidence-Based Obesity Prevention in Childcare
Obesity
Primary: Change in Educators' Observed Implementation Fidelity Scores for Use of Evidence-Based Obesity Practices — 4; 10; 2; 4 Classrooms
N/A N=65 Dietary Essential Fatty Acid Regulation of Omega-3 HUFA Metabolism; Satiety and Body Composition
Weight Gain · Healthy Subjects · Obesity
Primary: Proportion of n-6 HUFA in Total HUFA (%n-6 in HUFA) — 80.0; 81.3; 80.5 Percentage of total HUFA
N/A N=28 Exercise Effects on Word Learning
Aging · Aphasia
Primary: Study-Specific Word Recall Task — 6.4; 1.7; 4.6; 1.5 number of words gained